Log In
BCIQ
Print this Print this
 

Zofran, ondansetron

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionSerotonin (5-HT3) receptor antagonist
Molecular Target Serotonin (5-HT3) receptor
Mechanism of ActionSerotonin (5-HT3) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationEmesis
Indication DetailsEmesis; Prevent nausea and vomiting associated with general anesthesia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today